Showing 11-13 of 13 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Evaluation of Oxidized Insulin as a Biomarker and Therapeutic Target in Type 1 Diabetes | Trustees of Indiana University | Amelia Linnemann | Cures | 01-October-2023 to 31-December-2026 | $560,000.00 |
| A multiorgan autoimmune T-cell killing in-vitro platform to improve T1D drug screening | Indiana Biosciences Research Institute | Roberto Mallone | Cures | 01-June-2026 to 31-May-2027 | $196,040.47 |
| Exploiting SDF2L1 to protect against beta cell death and dysfunction in T1D | Indiana Biosciences Research Institute | Michael Kalwat | Cures | 01-December-2024 to 30-November-2027 | $748,169.00 |